J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4S):102179. doi: 10.1016/j.japh.2024.102179. Epub 2024 Aug 10.
Pharmacist-driven continuous glucose monitoring (CGM) is associated with reduced hemoglobin A1c (HbA1c) and achievement of daily glycemic goals. Community-based pharmacists are well-positioned to improve CGM uptake among patients with diabetes due to their accessibility and expertise. However, little data exist evaluating the outcomes of CGM services led by a community-based pharmacist.
To evaluate the impact of a community-based pharmacy resident-driven CGM service on HbA1c, revenue, and patient satisfaction.
Independent community pharmacy sharing a clinical services agreement with a primary care clinic for Postgraduate Year One (PGY1) Community-based Pharmacy Residents to provide patient care under general supervision of the physician.
Patients were offered CGM services if they were 18+ years with an HbA1c > 7.0% and had insurance coverage for CGM. Enrolled patients engaged in three months of pharmacist-led appointments for CGM application, data interpretation, diabetes education, and lifestyle management. Current Procedural Terminology (CPT) codes 99211, 95250, or 95251 were billed based on each encounter. HbA1c values were collected at program enrollment and conclusion. Patients completed a satisfaction survey at program conclusion.
Demographics and billed CPT codes were collected from the electronic health record. Descriptive statistics were used to analyze data.
Eighteen patients were included. A mean reduction of 1.2% occurred in HbA1c (n = 12; 9.7%-8.5%). Forty CPT codes were billed, generating $3671.40 of revenue. Satisfaction surveys were collected for 50% of participants (n = 9). Most were satisfied with the CGM service and its individual components (n = 8, 89%). Most were willing to continue using CGM devices and receive diabetes education from a pharmacist (n = 8, 89%).
A community-based pharmacist-led CGM service demonstrated a reduction in HbA1c and generated revenue for the clinic. Patients reported satisfaction and willingness to continue the service.
药师主导的连续血糖监测（CGM）可降低糖化血红蛋白（HbA1c）水平，并实现日常血糖目标。由于社区药师具有便捷性和专业知识，因此他们非常适合提高糖尿病患者对 CGM 的接受度。然而，关于社区药师主导的 CGM 服务的效果，目前数据有限。
评估由社区药师主导的 CGM 服务对糖化血红蛋白（HbA1c）、收入和患者满意度的影响。
一家独立的社区药房与初级保健诊所签订了临床服务协议，供住院医师 1 年（PGY1）社区药房住院医师为患者提供护理服务，在医生的一般监督下进行。
如果患者年龄在 18 岁以上，HbA1c＞7.0%，且有 CGM 保险覆盖，他们将获得 CGM 服务。入组患者接受三个月的药师主导的 CGM 应用、数据解读、糖尿病教育和生活方式管理预约。根据每次就诊情况，按 CPT 代码 99211、95250 或 95251 计费。在项目开始和结束时收集 HbA1c 值。患者在项目结束时完成满意度调查。
从电子健康记录中收集人口统计学和计费 CPT 代码。使用描述性统计分析数据。
共纳入 18 例患者。12 例（9.7%-8.5%）患者的 HbA1c 平均降低了 1.2%。共计费 40 个 CPT 代码，产生 3671.40 美元的收入。对 50%的参与者（n=9）收集了满意度调查。大多数人对 CGM 服务及其各个组成部分表示满意（n=8，89%）。大多数人愿意继续使用 CGM 设备并接受药师的糖尿病教育（n=8，89%）。
由社区药师主导的 CGM 服务可降低 HbA1c 水平，并为诊所带来收入。患者报告满意度高，愿意继续该服务。
